2023 ADVANCING DRUG DEVELOPMENT FORM AGENDA
Thursday, December 14th, 2023
Timing is approximate, and subject to change
Registration and Networking Continental Breakfast
Sponsored by TCG GreenChem
Welcome Address and Opening Remarks
Investment Panel: Best Practices to Managing and Raising Capital
Chaired by Bill Stienkrauss, CFO Owl Consulting
Panel:
- Chris Garabedian, CEO, Xontogeny and Portfolio Manager
- Danielle O’Neal, SVP Life Sciences, Banc of California
- Wasim Q Malik, Managing Partner at Iaso Ventures
Refreshment Break
Sponsored by Farmacon Global
When to Outsource - Difference Between Small and Large CDMOs
Moderator: Isaac Stoner, Chief Executive Officer at Octagon Therapeutics
Panel:
- Mark Bamforth, Entrepreneur, Mentor & Investor in life sciences
- Kevin Bittorf, Founder and Principal Consultant @ SCxCMC
- Karl Hansen, CTO Praxis Precision Medicines
Sponsored by Bend Bioscience
AI: The Next Frontier
Moderator: Ben Locwin, VP of Project Solutions
Panel:
- Keith Parent, Owner, Court Square Group, Inc.
- Lizabeth Leveille, Vice President and Head, Boston & European Innovation Hubs & Discovery Transactions at Merck
- Szczepan Baran, Chief Scientific Officer at VeriSIM Life
- Naren Tallapragada, CEO & Co-Founder at Tessel Bio
Sponsored by Court Square
Networking Lunch
Sponsored by Grand River
Academic Keynote: Rethinking the Journey from Idea to Medicine
The Harvard Medical School Therapeutics Initiative
Mark Namchuk, Executive Director Therapeutics Translation at Harvard Medical School
Bring Science & Innovation to Industry that Seems to be Resistant to Change
Chair: Roger Frechette, Chief Business Officer at Concerto Biosciences
Panel:
- Jack Derby, CEO Derby Management
- Max Shtein, CSO of Sublime
- Daniel Behr, EVP External Innovations & Academic Partnering at Ocean Biomedical
- Nancy Briefs, Co-Founder, President & CEO at AltrixBio
Sponsored by Austin PX
The Awakening of Women’s Health
Moderator: Shelley Amster, Co-Founder, Chief Strategy & Growth Officer at 3Daughters
Panel:
- Evan Sussman, CEO at Granata Bio
- Dawn McCollough, CEO at Progressive Therapeutics Inc.
- Cheri Ackerman, Cofounder & CEO at Concerto Biosciences
- John Tagliamonte, CEO, Mellitus LLC
- Mark Connell, Co-Founder/President, SLBST Pharma Inc.
Regulatory - FDA Modernization Act 2.0
Chair: David Kwajewski, Life Science Founder/Owner/Innovator
Panel:
- Colin Scott, Managing Partner & CEO Highland Airs Consulting
- Xiaoming Xu, Ph.D., Division Director at FDA
- Shawn Roach, Senior Consultant, Halloran Consulting Group, Inc.
- Dave Miller, Chief Scientific Officer at AustinPx
Sponsored by Halloran
Beer and Wine Tasting Event
Sponsored by Sannova
The Human Fear Factor
Chair: Missy Fulton, Founder & CEO Chameleon Strategies, LLC
Panel:
- Leslie J Williams, CEO at HC-Bio
- Ashley Iturralde, President at ARI Staffing
- Raman Sehgal, Author & Host of Molecule to Market podcast, Founder of ramarketing, Co-founder of Lead Candidate
Fire Side Chat: Where Are We Going?
Chair: Albine Martin, Co-Founder Accelevir Diagnostics
Panel:
- John Hallinan, Chief Development Officer at Danforth Advisors
- Bob Coughlin, Managing Director - Life Science and Healthcare
Networking
Hosted by Make-A-Wish Foundation
Registration is now open for the 2023 Forum
Contact Us
Have any questions?
For any inquiries on the presentations or partnerships, please contact us!
Advancing Drug Development Forum
